CXCR3 and neoplasm: Likewise, several studies have now clearly showed the anti-tumour activities of the CXCR3 ligands in various syngeneic tumour models (Luster and Leder, 1993; Sgadari et al, 1996; Addison et al, 2000; Dorsey et al, 2002; Feldman et al, 2002; Giese et al, 2002; Wang et al, 2003; Saudemont et al, 2005; Walser et al, 2007; Zipin-Roitman et al, 2007).